Anne Griffiths, MD

Anne Griffiths, MD

Specialty: Pediatric Pulmonology

Appointments Available in: Minneapolis (primary) & Minnetonka, accepting new patients

Education

Fellowship

  • Pediatric Pulmonology, Ann & Robert H. Lurie Children’s Hospital of Chicago – Northwestern University Feinberg School of Medicine – Chicago, IL

Internship/Residency

  • Pediatrics, Children’s Memorial Hospital — Northwestern University Feinberg School of Medicine — Chicago, IL

Medical school

  • University of Minnesota School of Medicine — Minneapolis, MN

Undergraduate

  • Northwestern University — Evanston, IL

Professional interests

  • Primary Ciliary Dyskinesia
  • Cystic Fibrosis
  • Asthma
  • Bronchiectasis
  • Noisy Breathing
  • Bronchoscopy
  • Non-Invasive Ventilation
  • Inhalational Lung Injury

Affiliations

  • Children’s Minnesota Primary Ciliary Dyskinesia PCDF Accredited Center, Medical Director
  • Member of the Centers for Disease Control and Prevention E-cigarette of Vaping Associated Lung Injury Response Clinical Working Group
  • Medical Expert, State of Minnesota, by its Attorney General, Keith Ellison v Juul Labs, Inc. f/k/a Pax Labs, Inc. and Altria Group, Inc. f/k/a Philip Morris Companies, Inc. District Court Fourth Judicial District. Court File # 27-CV-19-19888. Per Consent Judgment, Minnesota to receive $60.5 million per settlement with Juul and Altria.

Board Certification

  • Pediatrics
  • Pediatric Pulmonology

Publications

  • Ringshausen FC, Shapiro AJ, Nielsen KG, Griffiths A, et al. Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial. The Lancet Respiratory Medicine. Published online August 1, 2023. doi:https://doi.org/10.1016/s2213-2600(23)00226-6
  • Poplawska K, Griffiths A, Temme R, Adamko DJ, Nykamp K, Shapiro AJ. Deletions in DNAL1 Cause Primary Ciliary Dyskinesia Across North American Indigenous Populations. J Pediatr. 2023 Feb 23:S0022-3476(23)00121-X. doi: 10.1016/j.jpeds.2023.01.023. Epub ahead of print. PMID: 36841509.
  • Saba TG, Geddes GC, Ware SM, Schidlow DN, Del Nido PJ, Rubalcava NS, Gadepalli SK, Stillwell T, Griffiths A, Bennett Murphy LM, Barber AT, Leigh MW, Sabin N, Shapiro AJ. A multi-disciplinary, comprehensive approach to management of children with heterotaxy. Orphanet J Rare Dis. 2022 Sep 9;17(1):351. doi: 10.1186/s13023-022-02515-2. PMID: 36085154; PMCID: PMC9463860.
  • Messinger, Y. H., Pozos, T. C., Griffiths, A. G., Mize, W. A., Olson, D. R., &; Smith, A. R. (2021). Delayed diagnosis of GRISCELLI syndrome type 2 with compound heterozygote rab27a variants presenting with pulmonary failure. Pediatric Hematology and Oncology, 38(6), 593–601. https://doi.org/10.1080/08880018.2021.1895925
  • Kinghorn, B. A., McNamara, S., Genatossio, A., Sullivan, E., Siegel, M., Bauer, I., Clem, C., Johnson, R. C., Davis, M., Griffiths, A., Wheeler, W., Johnson, K., Davis, S. D., Leigh, M. W., Rosenfeld, M., & Pittman, J. (2020). Comparison of multiple breath washout and spirometry in children with primary ciliary dyskinesia and cystic fibrosis and Healthy Controls. Annals of the American Thoracic Society, 17(9), 1085–1093. https://doi.org/10.1513/annalsats.201905-375oc
  • Griffiths, A., Rauzi, A., Stadheim, K., & Wheeler, W. (2020). Lung injury associated with e-cigarette or vaping product use. Pediatric Annals, 49(2). https://doi.org/10.3928/19382359-20200120-01
  • Taylor J, Lung Injury Response Clinical Working Group (Griffiths, A), et al. Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement — Minnesota, 2018 and 2019. MMWR Morb Mortal Wkly Rep 2019;68:1096-1100. DOI: http://dx.doi.org/10.15585/mmwr.mm6847e1
  • Jatlaoui TC, Lung Injury Response Clinical Working Group (Griffiths, A), et al. Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019. MMWR Morb Mortal Wkly Rep 2019;68:1081-1086. DOI: http://dx.doi.org/10.15585/mmwr.mm6846e2
  • Jatlaoui TC, Lung Injury Response Clinical Working Group (Griffiths, A), et al. Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019. MMWR Morb Mortal Wkly Rep 2019;68:919–927. doi: http://dx.doi.org/10.15585/mmwr.mm6841e3
  • O’Connor, M. G., Griffiths, A., Iyer, N. P., Shapiro, A. J., Wilson, K. C., & Thomson, C. C. (2019). Summary for clinicians: Diagnosis of primary ciliary dyskinesia. Annals of the American Thoracic Society, 16(2), 171–174. https://doi.org/10.1513/annalsats.201810-693cme
  • Griffiths, A. G., Patwari, P. P., Loghmanee, D. A., Balog, M. J., Trosman, I., & Sheldon, S. H. (2017). Validation of polyvinylidene fluoride impedance sensor for respiratory event classification during polysomnography in children. Journal of Clinical Sleep Medicine, 13(02), 259–265. https://doi.org/10.5664/jcsm.6458
  • Griffiths A, Green T. “Chronic or Recurrent Respiratory Symptoms.” In: Kliegman RM, Stanton B, St. Geme J, etal. Nelson Textbook of Pediatrics 20th & 21st Ed. Philadelphia, PA: W.B Saunders Company, 2013, 2019, 2022.
  • Gregerson A, Daum RS. “Selected Vaccines of the Future: Staphylococcus aureus vaccine.” In: Vaccines. 4th ed. Ed. Stanley Plotkin and Walter Orenstein. Philadelphia: WB Saunders Company, 2003.

Personal Bio

Dr. Griffiths joined CRCCS in 2014 and serves as the Medical Director of our Primary Ciliary Dyskinesia (PCD) program in partnership with Children’s MN. Through her leadership and strong multi-disciplinary teamwork, we’re pleased to be recognized as nationally accredited center for PCD. As a former physician liaison to child life specialists, she appreciates the child’s unique experience of receiving medical care. She is married and has two children.